期刊文献+

抑郁症采用度洛西汀与阿戈美拉汀治疗的效果分析 被引量:4

下载PDF
导出
摘要 目的探讨抑郁症采用度洛西汀与阿戈美拉汀治疗的效果。方法选择我院2015年5月至2016年12月期间收治的80例抑郁症患者,随机分为对照组与观察组各40例,对照组运用度洛西汀治疗,观察组运用阿戈美拉汀治疗,分析两组患者治疗后疗效、不良反应情况差异。结果在治疗有效率上,观察组为90%,对照组为67.5%,两组差异具有统计学意义,P<0.05;在HAMD治疗前后评分上,观察组治疗后显著低于对照组,两组差异具有统计学意义,P<0.05;治疗不良反应率上,观察组为22.5%,对照组为47.5%,两组差异具有统计学意义,P<0.05。结论抑郁症采用阿戈美拉汀治疗可以有效的提升治疗疗效,降低治疗不良反应,治疗效果与安全更有保证。
作者 赵贵文
出处 《中国医药指南》 2017年第21期148-148,共1页 Guide of China Medicine
  • 相关文献

参考文献3

二级参考文献41

  • 1Bodinat C,Guardiola-Lemaitre B,Mocaer E,et al. Agomelatine,thefirst melatonergic antidepressant : discovery, characterization anddevelopment[ J] . Nat Rev Drug Discov,2010,9:628-642.
  • 2Kasper S,Hajak G,Wulff K,et al. Efficacy of the novel antidepres-sant agomelatine on the circadian rest-activity cycle and depressiveand anxiety symptoms in patients with major depressive disorder:arandomized,double-blind comparison with sertraline [ J ]. J ClinPsychiatiy,2010,71:109-120.
  • 3Quera-Salva MA,Hajak G,Philip P,et al. Comparison of agomela-tine and escitcdopram on nighttime sleep and daytime condition andefficacy in major depressive disorder patients [ J ]. Int Clin Psycho-pharmacol, 2011 ,26 :252-262.
  • 4Hickie IB, Rogers NL. Novel melatonin-based therapies: poten- tial advances in the treatment of major depresslon[J]. Lancet, 2011, 378(9791): 621-631.
  • 5Germain A, Kupfer DJ. Circadian rhythm disturbances in depres- sion[J]. Hum Psychopharmacol, 2008, 23(7): 571-585.
  • 6Souetre E, Salvati E, Belugou JL, et al. Circadian rhythms in de- pression and recovery: evidence for blunted amplitude as the main chronobiological abnormality[J]. Psychiatry Res, 1989, 28 (3): 263-278.
  • 7de Bodinat C, Guardiola-Lemaitre B, Moeaer E, et al. Agomela- tine, the first melatonergie antidepressant: discovery, character- ization and development[J]. Nat Rev Drug Discov, 2010, 9(8): 628-642.
  • 8Monteleone P, Maj M. The circadian basis of mood disorders: re- cent developments and treatment implications[J]. Eur Neuropsy- chopharmacol, 2008, 18(10): 701-711.
  • 9Kasper S, Hamon M. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action[J]. World J Biol Psychiatry, 2009, 10(2): 117-126.
  • 10Tardito D, Molteni R, Popoli M, et al. Synergistic mechanisms in- volved in the antidepressant effects of agomelatine[J]. Eur Neuro- psychopharmacol, 2012, 22 (Suppl 3) : $482-486.

共引文献67

同被引文献39

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部